Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma | |
Chao Wang; Yan Li; Chuan-min Chu; Xiang-min Zhang; Jie Ma; Hai Huang; Yu-ning Wang; Tian-yu Hong; Jing Zhang; Xiu-wu Pan | |
刊名 | EBioMedicine |
2019 | |
卷号 | Vol.39页码:255-264 |
关键词 | Renal cell carcinoma Gankyrin Prognosis Disease progression |
ISSN号 | 2352-3964 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4737378 |
专题 | 湖南大学 |
作者单位 | 1.e Department of Urinary Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin Road No. 2, Shanghai 200025, China f Department of Microbiology and Immunology, Weill Medical College of Cornell University, 1300 York Avenue, New York 10065-4805, NY, United States. 2.Ningxia Medical University, Yinchuan, Ningxia 750004, China a Department of Urinary Surgery, Gongli Hospital, Second Military Medical University , 219 Miaopu Road, Shanghai 200135, China 3.Department of Urinary Surgery, The Third Affiliated Hospital of Second Military Medical University , 700 North Moyu Road, Shanghai 201805, China 4.Department of Urology, Changhai Hospital, Second Military Medical University , 168 Changhai Road, Shanghai 200438, China |
推荐引用方式 GB/T 7714 | Chao Wang,Yan Li,Chuan-min Chu,et al. Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma[J]. EBioMedicine,2019,Vol.39:255-264. |
APA | Chao Wang.,Yan Li.,Chuan-min Chu.,Xiang-min Zhang.,Jie Ma.,...&Xin-gang Cui.(2019).Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.EBioMedicine,Vol.39,255-264. |
MLA | Chao Wang,et al."Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma".EBioMedicine Vol.39(2019):255-264. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论